Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review MS Salahudeen, SB Duffull, PS Nishtala BMC geriatrics 15, 1-14, 2015 | 516 | 2015 |
Comparison of anticholinergic risk scales and associations with adverse health outcomes in older people MS Salahudeen, SN Hilmer, PS Nishtala Journal of the American geriatrics society 63 (1), 85-90, 2015 | 186 | 2015 |
An overview of pharmacodynamic modelling, ligand-binding approach and its application in clinical practice MS Salahudeen, PS Nishtala Saudi Pharmaceutical Journal 25 (2), 165-175, 2017 | 182 | 2017 |
Anticholinergics: theoretical and clinical overview PS Nishtala, MS Salahudeen, SN Hilmer Expert opinion on drug safety 15 (6), 753-768, 2016 | 174 | 2016 |
Temporal trends in polypharmacy and hyperpolypharmacy in older New Zealanders over a 9-year period: 2005-2013 PS Nishtala, MS Salahudeen Gerontology 61 (3), 195-202, 2015 | 131 | 2015 |
Serum anticholinergic activity and cognitive and functional adverse outcomes in older people: a systematic review and meta-analysis of the literature MS Salahudeen, T Chyou, PS Nishtala PloS one 11 (3), e0151084, 2016 | 57 | 2016 |
A study on drug–drug interactions through prescription analysis in a South Indian teaching hospital V Kulkarni, SS Bora, S Sirisha, MS Salahudeen, S Sundaran Therapeutic advances in drug safety 4 (4), 141-6, 2013 | 57 | 2013 |
Esketamine: new hope for the treatment of treatment-resistant depression? A narrative review MS Salahudeen, CM Wright, GM Peterson Therapeutic advances in drug safety 11, 2042098620937899, 2020 | 56 | 2020 |
Impact of anticholinergic discontinuation on cognitive outcomes in older people: a systematic review MS Salahudeen, SB Duffull, PS Nishtala Drugs & aging 31, 185-192, 2014 | 53 | 2014 |
Association between anticholinergic drug burden and mortality in older people: a systematic review S Ali, GM Peterson, LR Bereznicki, MS Salahudeen European Journal of Clinical Pharmacology 76 (3), 319-335, 2020 | 44 | 2020 |
Study on the classification, causality, preventability and severity of adverse drug reaction using spontaneous reporting system in hospitalized patients S Sundaran, A Udayan, K Hareendranath, B Eliyas, B Ganesan, ... Pharmacy 6 (4), 108, 2018 | 42 | 2018 |
Examination and estimation of anticholinergic burden: current trends and implications for future research MS Salahudeen, PS Nishtala Drugs & aging 33 (5), 305-313, 2016 | 37 | 2016 |
The influence of patient characteristics on anticholinergic events in older people MS Salahudeen, PS Nishtala, SB Duffull Dementia and geriatric cognitive disorders extra 5 (3), 530-541, 2015 | 34 | 2015 |
Oral anticoagulant treatment and the risk of dementia in patients with atrial fibrillation: a population‐based cohort study WM Bezabhe, LR Bereznicki, J Radford, BC Wimmer, MS Salahudeen, ... Journal of the American Heart Association 11 (7), e023098, 2022 | 32 | 2022 |
Pharmacist‐led interventions to reduce adverse drug events in older people living in residential aged care facilities: A systematic review S Ali, MS Salahudeen, LRE Bereznicki, CM Curtain British Journal of Clinical Pharmacology 87 (10), 3672-3689, 2021 | 28 | 2021 |
Ten-year trends in the use of oral anticoagulants in Australian general practice patients with atrial fibrillation WM Bezabhe, LR Bereznicki, J Radford, BC Wimmer, C Curtain, ... Frontiers in Pharmacology 12, 586370, 2021 | 27 | 2021 |
A study of the factors affecting time to onset of lactogenesis-II after parturition MS Salahudeen, AM Koshy, S Sen Journal of Pharmacy Research 6 (1), 68-72, 2013 | 26 | 2013 |
A systematic review evaluating the use of the interRAI home care instrument in research for older people MS Salahudeen, PS Nishtala Clinical gerontologist 42 (5), 463-484, 2019 | 25 | 2019 |
Deprescribing medications in older people: a narrative review. MS Salahudeen Drugs of today (Barcelona, Spain: 1998) 54 (8), 489-498, 2018 | 25 | 2018 |
Study on the impact of patient counseling on the quality of life and pulmonary function of asthmatic patient MS Salahudeen, JJK Alhas, S Siraj Int J Pharm Pharm Sci 4 (Suppl 5), 300-4, 2012 | 22 | 2012 |